ISSN 1518 0557
An update systematic review on the treatment of primary dysmenorrhea

2019; 23
Maedeh Sharghi, , Shabnam Malekpour Mansurkhani, Damoon Ashtary-Larky, Wesam Kooti, Mehdi Niksefat, Milad Azami, Mohammad Firoozbakht, Masoud Behzadifar, Hadis Musavi, Leila Jouybari
JBRA Assist. Reprod. 2019; 23 (1):51-57

Received December 15, 2017
Accepted October 02, 2018
Abstract

Objectives: Primary dysmenorrhea is a painful uterine contraction caused by endometrial laceration. Chemical therapeutics and complementary medicine are used to treat dysmenorrhea. The aim of this study is to investigate and introduce updates of dysmenorrheal treatments. Methods: The present study was conducted in accordance with PRISMA checklist for systematic Reviews and meta-analyses. The required information was collected by searching for the key words: treatment, primary dysmenorrhea, medicinal plants, chemical drugs and herbs in the databases of Pubmed, Web of Sciences, Scopus, Iran medex and SID until March 2018. Search was done to access the English and Persian literature on this subject without time limitation. Results: 17 articles were reviewed in the study, including 10 studies on complementary medicine, 3 studies on chemical drugs and 4 studies for acupuncture and acupressure studies. The largest sample size was 303 and the smallest sample size was 24 patients who were in the clinical trials. The length of the treatment period varied from one to six months and the most commonly used measure in the studies was visual analogue scale and clinical efficacy. There were reports of complications such as gastrointestinal complications, nausea, vomiting, diarrhea, abdominal pain, liver and kidney disorders. Conclusion: Medicinal plants, chemical drugs, and acupressure seem to suppress the state of the pain by reducing the level of prostaglandins, mediating nitric oxide, increasing beta-endorphin levels, calcium channel block and circulatory flow through the uterine pathway. However, in order to ensure the benefits of procedures and the absence of complications, clinical trials are recommended


This Article

doi: 10.5935/1518-0557.20180083

Full Text (HTML)
Full Text (PDF)

Classifications

Review

How to cite

How to cite this article

Send this article

Send this article by mail

Access statistics

Last 30 days: 30
All time: 15723


Home

 
Copyright 2026 - JBRA Assisted Reproduction - All rights reserved.
Support and Maintenance by Eniosoft